Molbio Diagnostics Limited
Molbio Diagnostics Limited (MOLBIO) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Key metrics
Price as of 2026-09-07
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2026 |
|---|---|
| Sales | 408 Cr |
| Operating expenses (approx.) | 308 Cr |
| EBITDA | 101 Cr |
| OPM % | 24.6% |
| Other income | 3 Cr |
| Interest | 11 Cr |
| Depreciation | 17 Cr |
| Profit before tax | 76 Cr |
| Tax % | 30.5% |
| Net profit | 53 Cr |
| EPS (₹) | ₹5.21 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | TTM |
|---|---|
| Sales | Sign in for TTM |
| Operating expenses (approx.) | Sign in for TTM |
| EBITDA | Sign in for TTM |
| OPM % | Sign in for TTM |
| Other income | Sign in for TTM |
| Interest | Sign in for TTM |
| Depreciation | Sign in for TTM |
| Profit before tax | Sign in for TTM |
| Tax % | Sign in for TTM |
| Net profit | Sign in for TTM |
| EPS (₹) | Sign in for TTM |
| Dividend payout % | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
No data for this view.
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
No data for this view.
Ratios
Ratios as reported or derived per annual period.
No data for this view.